Biologic agents, including tumor necrosis factor-alpha (TNF-α) inhibitors, interleukin-6 (IL-6) receptor antagonists, and B-cell depleting agents, target specific components of the immune system and effectively suppress inflammation in RA [13]. This evidence concerns the gene TNF and rheumatoid arthritis.